the differential effects of nac treatment on the sulfhydryl content of tissues , the treatment 's inability to alter the course of bleomycin-induced lung inflammation and collagen accumulation , and the potential for exacerbation of lung toxicity in response to repeated administration of nac before exposure to fibrogenic agents are discussed .
C0032285
lung inflammation
C0001047
nac